BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22706399)

  • 21. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
    Man CH; Fung TK; Wan H; Cher CY; Fan A; Ng N; Ho C; Wan TS; Tanaka T; So CW; Kwong YL; Leung AY
    Blood; 2015 Jun; 125(25):3928-36. PubMed ID: 25940713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation.
    Ørskov AD; Treppendahl MB; Skovbo A; Holm MS; Friis LS; Hokland M; Grønbæk K
    Oncotarget; 2015 Apr; 6(11):9612-26. PubMed ID: 25823822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
    Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias].
    Kostroma II; Gritsaev SV; Sidorova ZY; Tiranova SA; Svitina SP; Drizhun YS; Chubukina ZV; Martynkevich IS; Kapustin SI; Bessmeltsev SS
    Ter Arkh; 2016; 88(7):31-36. PubMed ID: 27459612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome.
    Zhou JD; Lin J; Zhang TJ; Ma JC; Yang L; Wen XM; Guo H; Yang J; Deng ZQ; Qian J
    Cancer Med; 2017 Jan; 6(1):267-274. PubMed ID: 27891827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes.
    Gawlitza AL; Speith J; Rinke J; Sajzew R; Müller EK; Schäfer V; Hochhaus A; Ernst T
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2835-2843. PubMed ID: 31506740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of SRY-box containing gene family member
    Zhou JD; Wang YX; Zhang TJ; Li XX; Gu Y; Zhang W; Ma JC; Lin J; Qian J
    Clin Epigenetics; 2018; 10():92. PubMed ID: 30002740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
    Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
    Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome.
    Zhao G; Li N; Li S; Wu W; Wang X; Gu J
    Int J Oncol; 2019 Feb; 54(2):491-504. PubMed ID: 30535457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
    Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
    Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
    Mori N; Yoshinaga K; Tomita K; Ohwashi M; Kondoh T; Shimura H; Wang YH; Shiseki M; Okada M; Motoji T
    Leuk Res; 2011 Apr; 35(4):516-21. PubMed ID: 20828818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients.
    Li S; Fan R; Zhao XL; Wang XQ
    Leuk Res; 2014 Sep; 38(9):1072-8. PubMed ID: 25085016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Salvatore S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
    Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
    Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
    Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients.
    Chandra D; Tyagi S; Singh J; Deka R; Manivannan P; Mishra P; Pati HP; Saxena R
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3307-3313. PubMed ID: 29286224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.